作者
Yiqun Li,Wenyang Han,Pinni Yang,Yiming Jia,Lulu Sun,Ruirui Wang,Mengyao Shi,Xiaowei Zheng,Yonghong Zhang,Zhengbao Zhu
摘要
Associations between the differences of estimated glomerular filtration rate (eGFR diff ) based on cystatin C (eGFR cys ) and creatinine (eGFR cr ) and dementia risk remains unknown. This study aims to examine the associations between eGFR diff and dementia, including its common subtypes, and to explore whether there is a correlation of eGFR diff with cognitive functions and biological aging. A cohort consisting of 498,711 dementia-free participants was included based on the UK Biobank. The eGFR diff calculated as eGFR cys minus eGFR cr was categorized into three groups including negative (<−15 mL/min/1.73 m 2 ), midrange (−15–15 mL/min/1.73 m 2 ) and positive (≥15 mL/min/1.73 m 2 ). Multivariate Cox proportional hazards regression models, logistic regression models and general linear models were applied to explore associations of eGFR diff with dementia, cognitive functions and biological aging. During a median follow-up of 13 years, 8171 all-cause dementia [ACD, including 5144 Alzheimer's disease (AD) and 1593 vascular dementia (VD)] events were recorded. In multivariate models adjusting for genetic and biological factors, lifestyle factors and socioeconomic factors, participants with negative eGFR diff had a 27 % higher risk of ACD (HR = 1.27, 95 % CI: 1.20–1.34), worse cognitive functions and a 24 % ∼ 46 % increase in the risk of biological age acceleration, while there are significant associations of positive eGFR diff with lower risks of dementia, cognitive decline and biological aging, compared to those with a midrange eGFR diff . A negative eGFR diff (eGFR cys -eGFR cr < −15 mL/min/1.73m 2 ) was associated with a higher risk of dementia, poorer cognitive functions, and worse biological age acceleration. While those with a positive eGFR diff had a lower risk. • This cohort study investigates whether the difference between cystatin C-based (eGFR cys ) and creatinine-based (eGFR cr ) estimated glomerular filtration rate (eGFR diff ) is associated with dementia risk, cognitive functions, and biological aging. • A negative eGFR diff (eGFR cys -eGFR cr < -15 mL/min/1.73 m 2 ) was associated with a 27% higher risk of all-cause dementia, worse cognitive functions, and accelerated biological aging, independent of traditional risk factors. Conversely, a positive eGFR diff was linked to lower risks of dementia, cognitive decline, and slower biological aging. • The eGFRdiff serves as a novel, accessible biomarker that captures non-GFR determinants of renal biomarkers, providing a unique integrative measure for stratifying risk of dementia and aging-related outcomes, beyond conventional kidney function measures.